| 000 | 01882 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250511180347.0 | ||
| 264 | 0 | _c19921016 | |
| 008 | 199210s 0 0 eng d | ||
| 022 | _a1050-7256 | ||
| 024 | 7 |
_a10.1089/thy.1992.2.39 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarlow, J W | |
| 245 | 0 | 0 |
_aCharacterization of cytoplasmic T3 binding sites by adsorption to hydroxyapatite: effects of drug inhibitors of T3 and relationship to glutathione-S-transferases. _h[electronic resource] |
| 260 |
_bThyroid : official journal of the American Thyroid Association _c1992 |
||
| 300 |
_a39-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmiodarone _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBinding Sites _xdrug effects |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aCytosol _xmetabolism |
| 650 | 0 | 4 |
_aDiclofenac _xpharmacology |
| 650 | 0 | 4 |
_aDithiothreitol _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDurapatite |
| 650 | 0 | 4 |
_aFurosemide _xpharmacology |
| 650 | 0 | 4 |
_aGlutathione Transferase _xphysiology |
| 650 | 0 | 4 |
_aHydrocortisone _xpharmacology |
| 650 | 0 | 4 |
_aHydroxyapatites _xmetabolism |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIopanoic Acid _xpharmacology |
| 650 | 0 | 4 |
_aLiver _xmetabolism |
| 650 | 0 | 4 | _aMacaca fascicularis |
| 650 | 0 | 4 |
_aMefenamic Acid _xpharmacology |
| 650 | 0 | 4 |
_aSulfobromophthalein _xpharmacology |
| 650 | 0 | 4 |
_aTaurocholic Acid _xpharmacology |
| 650 | 0 | 4 |
_aTriiodothyronine _xantagonists & inhibitors |
| 700 | 1 | _aRaggatt, L E | |
| 700 | 1 | _aLim, C F | |
| 700 | 1 | _aTopliss, D J | |
| 700 | 1 | _aStockigt, J R | |
| 773 | 0 |
_tThyroid : official journal of the American Thyroid Association _gvol. 2 _gno. 1 _gp. 39-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/thy.1992.2.39 _zAvailable from publisher's website |
| 999 |
_c1332885 _d1332885 |
||